Search research articles
Contact Us
Filters
Showing results (1-10 of 34) with videos related to
Page
of 4
Sort By:
Current Opinion in Oncology
|
February 25, 2000
Myelodysplasia
R Dansey
Leukemia & Lymphoma
|
January 1, 1996
Aggressive non-Hodgkin's lymphoma: long-term results of full dose CHOP chemotherapy, and analysis of prognostic determinant
W R Bezwoda, R Dansey
Leukemia & Lymphoma
|
July 27, 2016
High-Dose Chemotherapy with Bone-Marrow Rescue for Treatment of Relapsed and Refractory Hodgkin's Disease
W R Bezwoda, R Dansey
Cancer Chemotherapy and Pharmacology
|
January 1, 1997
New concepts in the treatment of breast cancer using high-dose chemotherapy
W P Peters, R Dansey
Oncology
|
January 1, 1987
Correlation of breast tumour aromatase activity and response to aromatase inhibition with aminoglutethimide
W R Bezwoda, N Mansoor, R Dansey
Cancer
|
September 1, 1989
Intraperitoneal recombinant interferon-alpha 2b for recurrent malignant ascites due to ovarian cancer
W R Bezwoda, L Seymour, R Dansey
Oncology
|
January 1, 1990
High-dose 4'-epiadriamycin for treatment of breast cancer refractory to standard dose anthracycline chemotherapy: achievement of second responses
W R Bezwoda, R Dansey, L Seymour
Oncology
|
January 1, 1989
First-line chemotherapy of advanced breast cancer with mitoxantrone, cyclophosphamide and vincristine
W R Bezwoda, R Dansey, L Seymour
Leukemia & Lymphoma
|
December 1, 1996
Prolonged survival in follicular non Hodgkins lymphoma is predicted by achievement of complete remission with initial treatment: results of a long-term study with multivariate analysis of prognostic factors
M Davidge-Pitts, R Dansey, W R Bezwoda
Oncology
|
January 1, 1990
Treatment of Hodgkin's disease with MOPP chemotherapy: effect of dose and schedule modification on treatment outcome
W R Bezwoda, R Dansey, M A Bezwoda
Page
of 4
Search research articles
Search
Showing results (1-10 of 34) with videos related to
Sort By:
Page
of 4
Current Opinion in Oncology
|
February 25, 2000
Myelodysplasia
R Dansey
Leukemia & Lymphoma
|
January 1, 1996
Aggressive non-Hodgkin's lymphoma: long-term results of full dose CHOP chemotherapy, and analysis of prognostic determinant
W R Bezwoda, R Dansey
Leukemia & Lymphoma
|
July 27, 2016
High-Dose Chemotherapy with Bone-Marrow Rescue for Treatment of Relapsed and Refractory Hodgkin's Disease
W R Bezwoda, R Dansey
Cancer Chemotherapy and Pharmacology
|
January 1, 1997
New concepts in the treatment of breast cancer using high-dose chemotherapy
W P Peters, R Dansey
Oncology
|
January 1, 1987
Correlation of breast tumour aromatase activity and response to aromatase inhibition with aminoglutethimide
W R Bezwoda, N Mansoor, R Dansey
Cancer
|
September 1, 1989
Intraperitoneal recombinant interferon-alpha 2b for recurrent malignant ascites due to ovarian cancer
W R Bezwoda, L Seymour, R Dansey
Oncology
|
January 1, 1990
High-dose 4'-epiadriamycin for treatment of breast cancer refractory to standard dose anthracycline chemotherapy: achievement of second responses
W R Bezwoda, R Dansey, L Seymour
Oncology
|
January 1, 1989
First-line chemotherapy of advanced breast cancer with mitoxantrone, cyclophosphamide and vincristine
W R Bezwoda, R Dansey, L Seymour
Leukemia & Lymphoma
|
December 1, 1996
Prolonged survival in follicular non Hodgkins lymphoma is predicted by achievement of complete remission with initial treatment: results of a long-term study with multivariate analysis of prognostic factors
M Davidge-Pitts, R Dansey, W R Bezwoda
Oncology
|
January 1, 1990
Treatment of Hodgkin's disease with MOPP chemotherapy: effect of dose and schedule modification on treatment outcome
W R Bezwoda, R Dansey, M A Bezwoda
Page
of 4